A Study Exploring the Safety and Tolerability of INCB081776 in Participants With Advanced Malignancies

NCT03522142 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
83
Enrollment
INDUSTRY
Sponsor class

Stopped The study was terminated after careful review of the overall clinical activity of this compound and a lack of robust efficacy. The study closure is not based on safety concerns.

Conditions

Interventions

Sponsor

Incyte Corporation